Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer

被引:240
作者
Villafranca, E
Okruzhnov, Y
Dominguez, MA
García-Foncillas, J
Azinovic, I
Martínez, E
Ilarramendi, JJ
Arias, F
Monge, RM
Salgado, E
Angeletti, S
Brugarolas, A
机构
[1] Univ Navarra Clin, Dept Oncol, Pamplona 31008, Spain
[2] Hosp Navarre, Dept Oncol, Pamplona, Spain
关键词
D O I
10.1200/JCO.2001.19.6.1779
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Thymidylate synthase (TS) is an important target enzyme for the fluoropyrimidines. TS gene promoter possesses regulatory tandemly repeated (TR) sequences that are polymorphic in humans, depending on ethnic factors. These polymorphisms have been reported to influence TS expression. TS expression levels affect tumor downstaging after preoperative fluoruracil (5-FU)-based chemoradiation. Tumor downstaging correlates with improved local control and disease-free survival. The aim of this study is to correlate TR polymorphisms with downstaging and disease-free survival. Patients and Methods: Sixty-five patients with rectal cancer underwent tumor resection after preoperative 5-FU-based chemoradiation. Tumor downstaging was evaluated by comparing the pretreatment T stage with the pathologic stage observed in the surgical specimen. TS polymorphism genotype was determined by polymerase chain reaction amplification of the corresponding TS promoter region, and products of amplification were electrophoresed, obtaining products of 220 bp (2/2), 248 bp (3/3), or both (2/3). The TS polymorphism genotype results were subsequently compared with the downstaging observed and with disease-free survival. Results: Patients who were homozygous for triple TR (3/3) had a lower probability of downstaging than patients who were homozygous with double TR or heterozygous patients (2/2 and 2/3): 22% versus 60% (P = .036; logistic regression). Furthermore, a trend toward improved 3-year disease-free survival was detected in the 2/2 and 2/3 groups, compared with that in the 3/3 group (81% v 41%; P =.17). Conclusion: This preliminary study suggests that TS repetitive-sequence polymorphisms are predictive for tumor downstaging. TR sequences in TS promoter may be useful as a novel means of predicting response to preoperative 5-FU-based chemoradiation. (C) 2001 by American Society of Clinical Oncology.
引用
收藏
页码:1779 / 1786
页数:8
相关论文
共 36 条
  • [1] p53 status:: an indicator for the effect of preoperative radiotherapy of rectal cancer
    Adell, G
    Sun, XF
    Stål, O
    Klintenberg, C
    Sjödahl, R
    Nordenskjöld, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 1999, 51 (02) : 169 - 174
  • [2] Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy
    Aschele, C
    Debernardis, D
    Casazza, S
    Antonelli, G
    Tunesi, G
    Baldo, C
    Lionetto, R
    Maley, F
    Sobrero, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1760 - 1770
  • [3] AZINOVIC I, 1998, REV CANC, V12, P125
  • [4] Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications
    Berger, C
    deMuret, A
    Garaud, P
    Chapet, S
    Bourlier, P
    ReynaudBougnoux, A
    Dorval, E
    deCalan, L
    Huten, N
    leFloch, O
    Calais, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03): : 619 - 627
  • [5] Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
    Francois, Y
    Nemoz, CJ
    Baulieux, J
    Vignal, J
    Grandjean, JP
    Partensky, C
    Souquet, JC
    Adeleine, P
    Gerard, JP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2396 - 2402
  • [6] PREOPERATIVE RADIOTHERAPY AS ADJUVANT TREATMENT IN RECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC)
    GERARD, A
    BUYSE, M
    NORDLINGER, B
    LOYGUE, J
    PENE, F
    KEMPF, P
    BOSSET, JF
    GIGNOUX, M
    ARNAUD, JP
    DESAIVE, C
    DUEZ, N
    [J]. ANNALS OF SURGERY, 1988, 208 (05) : 606 - 614
  • [7] Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favoring preoperative treatment
    Glimelius, B
    Isacsson, U
    Jung, B
    Pahlman, L
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02): : 281 - 287
  • [8] FUNCTIONAL-ANALYSIS AND DNA POLYMORPHISM OF THE TANDEMLY REPEATED SEQUENCES IN THE 5'-TERMINAL REGULATORY REGION OF THE HUMAN GENE FOR THYMIDYLATE SYNTHASE
    HORIE, N
    AIBA, H
    OGURO, K
    HOJO, H
    TAKEISHI, K
    [J]. CELL STRUCTURE AND FUNCTION, 1995, 20 (03) : 191 - 197
  • [9] PREOPERATIVE RADIOTHERAPY IN OPERABLE RECTAL-CANCER
    HORN, A
    HALVORSEN, JF
    DAHL, O
    [J]. DISEASES OF THE COLON & RECTUM, 1990, 33 (10) : 823 - 828
  • [10] Hosmer W., 2000, Applied Logistic Regression, VSecond